Cargando…
Prospective unmasked randomized evaluation of the iStent inject(®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma
PURPOSE: The purpose of this study was to compare outcomes of subjects with open-angle glaucoma (OAG) not controlled on one medication who underwent either implantation of two iStent inject(®) trabecular micro-bypass devices or received medical therapy consisting of a fixed combination of latanopros...
Autores principales: | Fea, Antonio M, Belda, Jose I, Rękas, Marek, Jünemann, Anselm, Chang, Lydia, Pablo, Luis, Voskanyan, Lilit, Katz, L Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019628/ https://www.ncbi.nlm.nih.gov/pubmed/24855336 http://dx.doi.org/10.2147/OPTH.S59932 |
Ejemplares similares
-
Prospective, Unmasked Evaluation of the iStent(®)Inject System for Open-Angle Glaucoma: Synergy Trial
por: Voskanyan, Lilit, et al.
Publicado: (2014) -
Prospective Evaluation of Two iStent(®) Trabecular Stents, One iStent Supra(®) Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
por: Myers, Jonathan S., et al.
Publicado: (2018) -
Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication
por: Katz, L Jay, et al.
Publicado: (2015) -
Treatment of Open-Angle Glaucoma with iStent Implantation Combined with Phacoemulsification in Polish Caucasian Population
por: Kozera, Milena, et al.
Publicado: (2021) -
Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes
por: Katz, L Jay, et al.
Publicado: (2018)